Real-world experience with cladribine in the two years since treatment start: A systematic review and meta-analysis.
- DOI
- 10.1016/j.msard.2025.106600
- Published
- 2025 Nov
- Container
- Multiple sclerosis and related disorders
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.msard.2025.106600,
title = {Real-world experience with cladribine in the two years since treatment start: A systematic review and meta-analysis.},
author = {Albanese A and Schiavetti I and Sormani MP},
year = {2025},
journal = {Multiple sclerosis and related disorders},
doi = {10.1016/j.msard.2025.106600},
url = {https://doi.org/10.1016/j.msard.2025.106600}
}RIS
TY - JOUR TI - Real-world experience with cladribine in the two years since treatment start: A systematic review and meta-analysis. AU - Albanese A AU - Schiavetti I AU - Sormani MP PY - 2025 JO - Multiple sclerosis and related disorders DO - 10.1016/j.msard.2025.106600 UR - https://doi.org/10.1016/j.msard.2025.106600 ER -
APA
A, A., I, S., & MP, S. (2025). Real-world experience with cladribine in the two years since treatment start: A systematic review and meta-analysis.. Multiple sclerosis and related disorders. https://doi.org/10.1016/j.msard.2025.106600
Source records
- pubmed · retrieved 2026-09-26T20:49:56.334Z